TVTX - Travere Therapeutics, Inc.

QQQ $ 592.82 $ 0.00 (0 %)

DIA $ 455.78 $ 0.00 (0 %)

SPY $ 654.05 $ 0.00 (0 %)

TLT $ 91.53 $ 0.00 (0 %)

GLD $ 399.65 $ 0.00 (0 %)

Previous Close

$ 27.51

Open

$ 27.09

Bid

$ 25.97 x 3

Ask

$ 26.68 x 30

Day's Range

-- - --

52 Week Range

$ 12.91 - $ 28.69

Volume

2,296,203

Average Volume

Market Cap

2.45B

Beta (5Y Monthly)

$ 0.97

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-21-2025	12-31-2024	10-K
4	10-31-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-06-2024	03-31-2024	10-Q
7	02-20-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	02-23-2023	12-31-2022	10-K
12	10-27-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	10-29-2021	09-30-2021	10-Q
17	07-29-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	07-31-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	02-24-2020	12-31-2019	10-K
24	10-30-2019	09-30-2019	10-Q
25	08-06-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	02-26-2019	12-31-2018	10-K
28	11-01-2018	09-30-2018	10-Q
29	08-03-2018	06-30-2018	10-Q
30	05-01-2018	03-31-2018	10-Q
31	02-27-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-05-2017	03-31-2017	10-Q
35	03-01-2017	12-31-2016	10-K
36	11-04-2016	09-30-2016	10-Q
37	08-05-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	02-26-2016	12-31-2015	10-K
40	11-06-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

novartis-strengthens-kidney-disease-pipeline-with-promising-data

Novartis Strengthens Kidney Disease Pipeli...
10/16/2025 14:50:29

Novartis' Fabhalta showed significant efficacy and safety in a Phase 3 IgA nephropathy study, supporting regulatory filings...

10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

KDIGO 2025 Guidelines Endorse FILSPARI By ...
09/26/2025 07:24:20

FILSPARI (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss

The Analyst Verdict: Travere Therapeutics ...
09/19/2025 13:01:29

HC Wainwright & Co. Reiterates Buy on Trav...
09/19/2025 12:19:12

HC Wainwright & Co. analyst Joseph Pantginis reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $47 ...

Stifel Maintains Hold on Travere Therapeut...
09/12/2025 14:29:00

Stifel analyst Alex Thompson maintains Travere Therapeutics (NASDAQ:TVTX) with a Hold and raises the price target from $20 t...

Wells Fargo Maintains Overweight on Traver...
09/11/2025 12:38:37

Wells Fargo analyst Mohit Bansal maintains Travere Therapeutics (NASDAQ:TVTX) with a Overweight and raises the price target ...

travere-shares-are-trading-higher-wednesday-whats-going-on

Travere Shares Are Trading Higher Wednesda...
09/10/2025 19:52:26

12 Health Care Stocks Moving In Wednesday'...
09/10/2025 17:07:06

HC Wainwright & Co. Reiterates Buy on Trav...
09/10/2025 16:40:59

HC Wainwright & Co. analyst Joseph Pantginis reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $47 ...

daktronics-potbelly-coreweave-gamestop-and-other-big-stocks-moving-higher-on-wednesday

Daktronics, Potbelly, CoreWeave, GameStop ...
09/10/2025 14:56:32

Travere Therapeutics Announces FDA Drops A...
09/10/2025 11:03:38

Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced that the U.S. Food and Drug Administration (FDA) has informed the Com...

HC Wainwright & Co. Reiterates Buy on Trav...
09/03/2025 14:41:49

HC Wainwright & Co. analyst Joseph Pantginis reiterates Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $47 ...

UPDATE: Travere Therapeutics Presents Long...
09/03/2025 12:46:01

Presentation details long-term safety and efficacy data on pegtibatinase as a potential treatment for classical HCUTravere Ther...

fda-eases-monitoring-burden-for-kidney-disease-patients-on-travere-therapeutics-filspari

FDA Eases Monitoring Burden For Kidney Dis...
08/28/2025 16:40:43

FDA eases REMS labeling for Travere's Filspari, reducing liver monitoring and removing embryo-fetal toxicity rules, with FS...

Nvidia To Rally Around 27%? Here Are 10 To...
08/28/2025 13:34:02

Deep Dive Into Travere Therapeutics Stock:...
08/28/2025 12:00:30

HC Wainwright & Co. Maintains Buy on Trave...
08/28/2025 10:45:38

HC Wainwright & Co. analyst Joseph Pantginis maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the pric...

Travere Therapeutics Announces FDA Eases F...
08/27/2025 21:10:29

FDA simplifies liver monitoring schedule from monthly to every three months for the duration of treatment and removes embryo-fe...

hedge-fund-viking-global-dumps-unitedhealth-loads-up-on-amd-disney-jpmorgan-in-q2-shake-up

Hedge Fund Viking Global Dumps UnitedHealt...
08/15/2025 12:17:07

Andreas Halvorsen's Viking Global adjusted its stock portfolio in Q2, cutting healthcare exposure and adding consumer brand...